Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers
Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers
3 other identifiers
interventional
13
1 country
1
Brief Summary
This pilot clinical trial studies cognitive behavioral therapy in treating anxiety in patients with stage IV non-small cell lung cancer and their caregivers. Cognitive behavioral therapy may reduce anxiety and improve the well-being and quality of life of patients who have stage IV non-small cell lung cancer and their caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 14, 2012
CompletedFirst Posted
Study publicly available on registry
November 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedAugust 22, 2014
August 1, 2014
1 year
November 14, 2012
August 20, 2014
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility, defined as 75% of participants complete at least 5 sessions, 75% of participants complete pre- and post-intervention assessment battery
Up to 7 weeks
Acceptability, based on qualitative analysis of exit interviews
Up to 7 weeks
Study Arms (1)
Supportive care (cognitive behavioral therapy)
EXPERIMENTALParticipants undergo cognitive behavioral therapy over 1 hour once weekly for a total of 6 sessions. Sessions are tailored to patient and caregiver cognitions and approach and avoidance behaviors.
Interventions
Undergo cognitive behavioral therapy
Ancillary studies
Eligibility Criteria
You may qualify if:
- Diagnosis of stage IV non-small cell lung cancer
- At least 6 weeks post-diagnosis
- Current symptoms of anxiety (e.g., Hamilton Rating Scale for Anxiety \[HAM-A\] \>=14)
- Ability to understand and the willingness to sign a written informed consent document
- CAREGIVER: Identified by patient as primary caregiver
- CAREGIVER: At least 14 hours/week spent caring for patient
- CAREGIVER: Current symptoms of anxiety (e.g., HAM-A \>= 14)
- CAREGIVER: Ability to understand and the willingness to sign a written informed consent document
You may not qualify if:
- PATIENTS AND CAREGIVERS:
- Active, unstable, untreated serious mental illness
- Other cognitive inability to complete informed consent process or study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Stanford University
Stanford, California, 94305, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ellen Hendriksen
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor, Psychiatry & Behavioral Science - Behavioral Medicine
Study Record Dates
First Submitted
November 14, 2012
First Posted
November 20, 2012
Study Start
November 1, 2012
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
August 22, 2014
Record last verified: 2014-08